Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
Here is the latest financial fact sheet of SYNCOM HEALTHCARE. For more details, see the SYNCOM HEALTHCARE quarterly results and SYNCOM HEALTHCARE share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.7 |
No. of shares | m | 40.00 |
1 Week | % | -5.3 |
1 Month | % | 31.2 |
1 Year | % | 50.4 |
52 week H/L | Rs | 5.8/1.1 |
No. of Mths Year Ending |
12 Mar-16* |
12 Mar-17* |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
5-Yr Chart Click to enlarge
|
---|
SYNCOM HEALTHCARE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 15 | 10 | 9 | 6 | 2 | |
Low | Rs | 4 | 5 | 4 | 1 | 1 | |
Sales per share (Unadj.) | Rs | 31.0 | 13.7 | 10.3 | 16.0 | 5.0 | |
Earnings per share (Unadj.) | Rs | -0.9 | -26.8 | -19.6 | -2.9 | -2.9 | |
Diluted earnings per share | Rs | -0.9 | -26.8 | -19.6 | -2.9 | -2.9 | |
Cash flow per share (Unadj.) | Rs | 0.3 | -25.7 | -18.6 | -2.1 | -2.4 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 50.7 | 22.2 | 2.6 | -0.2 | -3.1 | |
Adj. book value per share | Rs | 50.7 | 22.2 | 2.6 | -0.2 | -3.1 | |
Shares outstanding (eoy) | m | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 | |
Price / Sales ratio | x | 0.3 | 0.6 | 0.6 | 0.2 | 0.3 | |
Avg P/E ratio | x | -11.6 | -0.3 | -0.3 | -1.3 | -0.5 | |
P/CF ratio (eoy) | x | 32.9 | -0.3 | -0.3 | -1.7 | -0.6 | |
Price / Book Value ratio | x | 0.2 | 0.3 | 2.4 | -16.2 | -0.5 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 398 | 307 | 250 | 146 | 61 | |
Total wages/salary | Rs m | 90 | 88 | 103 | 113 | 50 |
SYNCOM HEALTHCARE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,239 | 547 | 412 | 641 | 200 | |
Other income | Rs m | 30 | 23 | 4 | 3 | 3 | |
Total revenues | Rs m | 1,269 | 569 | 417 | 644 | 202 | |
Gross profit | Rs m | 7 | -940 | -747 | -84 | -94 | |
Depreciation | Rs m | 46 | 46 | 37 | 29 | 23 | |
Interest | Rs m | 33 | 31 | 3 | 4 | 3 | |
Profit before tax | Rs m | -42 | -994 | -782 | -114 | -117 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | -8 | 79 | 0 | 0 | 0 | |
Profit after tax | Rs m | -34 | -1,073 | -782 | -114 | -117 | |
Gross profit margin | % | 0.6 | -172.0 | -181.1 | -13.1 | -47.1 | |
Effective tax rate | % | 18.9 | -8.0 | 0 | 0 | 0 | |
Net profit margin | % | -2.8 | -196.4 | -189.8 | -17.8 | -58.7 |
SYNCOM HEALTHCARE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 2,009 | 1,001 | 423 | 344 | 47 | |
Current liabilities | Rs m | 293 | 332 | 452 | 382 | 182 | |
Net working cap to sales | % | 138.5 | 122.5 | -6.9 | -5.9 | -67.7 | |
Current ratio | x | 6.9 | 3.0 | 0.9 | 0.9 | 0.3 | |
Inventory Days | Days | 40 | 68 | 18 | 8 | 32 | |
Debtors Days | Days | 484,964,838 | 4,654 | 1,491 | 1,015 | 46 | |
Net fixed assets | Rs m | 342 | 303 | 185 | 151 | 131 | |
Share capital | Rs m | 400 | 400 | 400 | 400 | 400 | |
"Free" reserves | Rs m | 1,628 | 486 | -295 | -409 | -524 | |
Net worth | Rs m | 2,028 | 886 | 105 | -9 | -124 | |
Long term debt | Rs m | 107 | 83 | 48 | 117 | 117 | |
Total assets | Rs m | 2,362 | 1,304 | 609 | 495 | 178 | |
Interest coverage | x | -0.3 | -31.1 | -277.4 | -26.5 | -39.6 | |
Debt to equity ratio | x | 0.1 | 0.1 | 0.5 | -12.9 | -0.9 | |
Sales to assets ratio | x | 0.5 | 0.4 | 0.7 | 1.3 | 1.1 | |
Return on assets | % | 0 | -79.9 | -128.1 | -22.2 | -64.1 | |
Return on equity | % | -1.7 | -121.1 | -747.2 | 1,264.4 | 94.4 | |
Return on capital | % | -0.4 | -99.3 | -511.7 | -102.1 | 1,591.9 | |
Exports to sales | % | 2.1 | 3.7 | 3.2 | 3.4 | 0.5 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 26 | 20 | 13 | 22 | 1 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 26 | 20 | 13 | 22 | 1 | |
Fx outflow | Rs m | 3 | 6 | 1 | 0 | 0 | |
Net fx | Rs m | 23 | 14 | 13 | 22 | 1 |
SYNCOM HEALTHCARE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -80 | 42 | 57 | 13 | -1 | |
From Investments | Rs m | 94 | 49 | -10 | -3 | 6 | |
From Financial Activity | Rs m | -9 | -96 | -48 | -10 | -3 | |
Net Cashflow | Rs m | 5 | -6 | -2 | 1 | 2 |
Share Holding
Shareholding as on Jun 2021
|
Company Information
|
CHM: Ajay Shankarlal Bankda | COMP SEC: Farida Bhatia | YEAR OF INC: 2002 | BSE CODE: 533157 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare SYNCOM HEALTHCARE With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.